2023
Year In Review
In 2023 we celebrated 7 years of successful business
Our working community increased to 600+ employees
Two offices were opened, giving SmithRx four in-person locations
Our teams were enhanced. One of which being the Member Support team that grew by 200%
New Member Portal tools were launched like Find My Meds and Member chat
We added new and improved Connect 360 Programs, including:
Low Cost Insulin
Humira Biosimilars
Diabetes Non-Insulin
![](https://cdn.prod.website-files.com/6536ac4fdd18f5206e3916b7/6581eee4dc65f9d914e0487a_2023-bg.jpg)
We achieved over 500k Members under management
SmithRx grew its employer base to 3,500+ clients
![](https://cdn.prod.website-files.com/6536ac4fdd18f5206e3916b7/6581f01feae7cf84fb8d834d_pill-bg.jpg)
We saved our employer groups over $200M delivered from Connect 360 programs
Our data integrations expanded to include 100+ TPA integrations
We're consistently saving employers 20% or more of their total drug costs compared to legacy PBMs
![](https://cdn.prod.website-files.com/6536ac4fdd18f5206e3916b7/6581f20c4054e0c5b6e5095e_exclamation-bg.jpg)
We began two new partnerships this year including Mark Cuban Cost Plus Drugs and Amazon Pharmacy
![](https://cdn.prod.website-files.com/6536ac4fdd18f5206e3916b7/6581f27b730fe5b30009ced4_star-bg.jpg)
And finally, with our average member satisfaction at 4.3 stars on Google Reviews, SmithRx is leading the PBM industry with excellent customer care.
That’s a wrap! Thank you for an incredible year.
We look forward to working with you in 2024 and beyond.
See more of our 2023 Year in Review